Latest News

The study aims to collect data to optimize the design of the treatment’s upcoming phase 3 clinical trial.
First Patient Dosed in Pharmacokinetics Study of AD04 for Alcohol Use Disorder

June 5th 2024

The study aims to collect data to optimize the design of the treatment’s upcoming phase 3 clinical trial.

How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
An Update on GLP-1 Receptor Agonists as Pharmacotherapies for AUD

June 5th 2024

An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.
Efficacy of Semaglutide for the Treatment of Substance Use Disorders

May 29th 2024

Write to us now for a chance to be featured in our upcoming Special Report on Addiction.
Join Us for a Deep Dive Into Addiction

May 24th 2024

Here are highlights from the week in Psychiatric Times.
The Week in Review: May 6-10

May 11th 2024

Latest CME Events & Activities

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.